Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page
- Check5 days agoChange DetectedThe study Locations sections were updated: new locations were added and existing ones removed, altering the list of recruiting sites. A revision tag (Revision: v3.3.3) was added to the page.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.3.2 appears on the page header, replacing the previous Revision: v3.3.1. This is a minor update with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedA clarifying line stating that publications are automatically filled from PubMed was added to the Publications section, and the footer revision now shows v3.3.1. The previous PubMed note and the old v3.2.0 revision text were removed.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved the government funding lapse notice and related operating-status information from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedNo substantive changes detected between the old and new screenshots of the ClinicalTrials.gov study page; content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference2%

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.